2014
DOI: 10.3109/09553002.2014.965603
|View full text |Cite
|
Sign up to set email alerts
|

11th International Conference on Health Effects of Incorporated Radionuclides

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…The areas of study have expanded in recent years with applications in the fields of nuclear toxicology [3][4][5][6], cancer therapy (e.g., the radioisotope 225 Ac of actinium is an alpha emitter useful for targeted radiotherapy [7]), analytical chemistry [8], and in basic research in structural chemistry and reaction mechanisms [9]. All these applications have in common the need to develop pre-organised chelating agents.…”
Section: Introductionmentioning
confidence: 99%
“…The areas of study have expanded in recent years with applications in the fields of nuclear toxicology [3][4][5][6], cancer therapy (e.g., the radioisotope 225 Ac of actinium is an alpha emitter useful for targeted radiotherapy [7]), analytical chemistry [8], and in basic research in structural chemistry and reaction mechanisms [9]. All these applications have in common the need to develop pre-organised chelating agents.…”
Section: Introductionmentioning
confidence: 99%